ACART is seeking feedback on proposed advice to the Minister of Health that the use of cryopreserved ovarian tissue to restore ovarian function become an established procedure. Currently women in New Zealand can cryopreserve and store ovarian tissue, but are unable to use it in New Zealand. ACART has reviewed recent evidence and considered the risks, benefits and ethical issues associated with the use of cryopreserved ovarian tissue to restore ovarian function. ACART is proposing that the use of cryopreserved ovarian tissue to restore ovarian function should become an established procedure.
ACART is seeking feedback by 27th June.
The consultation document is available online here: ACART Consultation Cyropreserved ovarian tissue
Feedback due: Please send feedback to marilynh@nzno.org.nz by 27 June 2016.